Gilead Sciences’ (GILD) highly anticipated HIV prevention drug, Yeztugo, beat second-quarter expectations late Tuesday, allaying analysts’ concerns over soft prescription trends. However, Gilead stock toppled Wednesday. The Street’s focus landed on HIV treatment powerhouses Biktarvy and Descovy. The duo “beat considerably, even if helped somewhat by pricing and favorable inventory … and seasonal dynamics,” RBC…
SpaceX earnings impressed, but did little to the young, moribund stock. Any investors hoping the report might do have done the same for the languishing shares of Elon Musk’s other company, Tesla, were also disappointed. SpaceX (SPCX) stock fell 13.6% on Wednesday, according to MarketSurge. Tesla (TSLA) slipped 1.8%. SpaceX reported earnings for the first…
Amgen (AMGN) stock popped Wednesday on what one analyst called an “impressive” quarter featuring double-digit growth for nearly two dozen of its products. The best growth came from Uplizna, a treatment for several rare autoimmune conditions. Sales nearly doubled, rocketing 90% to $335 million. Meanwhile, revenue from the company’s biggest moneymaker, cholesterol drug Repatha, surged…
Mortgage rates fell this week, with the 30-year fixed rate averaging 6.63%, down from 6.67% last week, according to Bankrate’s latest lender survey. Current mortgage rates The 30-year fixed mortgages in this week’s survey had an average total of 0.26 discount and origination points. Discount points are a way to lower your mortgage rate, while…
Strategy’s (NASDAQ: $MSTR) high-yielding preferred stock (NASDAQ: $STRC) is recovering as the serial cryptocurrency acquirer prioritizes building up its cash reserves. The preferred stock is trading at $94 U.S. on Aug. 5, having gained 6% in the last five trading sessions and risen more than 30% from its June low. STRC stock bottomed in late…
The dollar index (DXY00) fell by -0.17% on Wednesday. The dollar fell on Wednesday after the S&P 500 climbed to a new record high, reducing demand for dollar liquidity. Also, Wednesday’s weaker-than-expected reports on July ADP employment and July ISM services were bearish for the dollar. Losses in the dollar are limited on hawkish comments…
What happened: Eli Lilly (LLY) stock jumped as much as 7% on Wednesday. What’s behind the move: The drug company raised its 2026 sales forecast after it saw strong demand for GLP-1 drugs in its fiscal second quarter. Revenue is now expected to fall between $85 billion and $87 billion for the year, topping an earlier…
By Maggie Fick and Sabrina Valle Aug 5 (Reuters) – There are “no discussions” ongoing between AstraZeneca and Bristol Myers Squibb over a potential deal, a senior source close to the matter told Reuters on Wednesday, quashing the prospect of a mooted mega merger between the drugmakers. “There is no deal between AstraZeneca and BMS….
Gator Capital Management, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. In the Q2 2026 investor letter from Gator Capital Management, the firm reported strong absolute performance across its funds, demonstrating notable outperformance relative to the Financials sector, even though it slightly lagged the…
SpaceX (NASDAQ: $SPCX) has reported a $540 million U.S. paper loss on its Bitcoin (CRYPTO: $BTC) holdings. The commercial space company led by Elon Musk maintained its holdings of 18,712 Bitcoin, according to the company’s first earnings report as a public company. However, the value of SpaceX’s BTC holdings declined to $1.10 billion U.S. by…
End of content
End of content